We are live on
!
Find out more
ACM
Alethea Capital Management Portfolio holdings
AUM
$195M
1-Year Est. Return
51.17%
This Fund
S&P 500
This Quarter
Est. Return
+7.76%
1 Year Est. Return
+51.17%
3 Year Est. Return
+200.24%
5 Year Est. Return
+277.75%
10 Year Est. Return
+2,049.08%
AUM
$138M
AUM Growth
+$6.67M
(+5.1%)
Cap. Flow
-$2.7M
Cap. Flow
% of AUM
-1.95%
Top 10 Holdings %
Top 10 Hldgs %
94.96%
Holding
50
New
19
Increased
1
Reduced
4
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kura Oncology
KURA
|
+$5.83M |
| 2 |
Hasbro
HAS
|
+$411K |
| 3 |
Weyerhaeuser
WY
|
+$405K |
| 4 |
Baxter International
BAX
|
+$402K |
| 5 |
Exelon
EXC
|
+$398K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RNAM
Avidity Biosciences
RNAM
|
+$3.3M |
| 2 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$3.29M |
| 3 |
Synchrony
SYF
|
+$574K |
| 4 |
Amgen
AMGN
|
+$557K |
| 5 |
Extra Space Storage
EXR
|
+$539K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 71.26% |
| 2 | Consumer Discretionary | 1.18% |
| 3 | Industrials | 1.16% |
| 4 | Consumer Staples | 1.08% |
| 5 | Communication Services | 0.6% |
Similar funds
WM
LWA
CPI
WAL
NLWP
ICMARC
RAM
MHFA
Alethea Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Alethea Capital Management held 50 positions worth $138M, up 5.1% from $132M the previous quarter. Its ten largest holdings account for 95% of the portfolio.
Alethea Capital Management's Q3 2024 filing shows 19 new, 1 increased, 4 reduced and 20 closed positions. Its largest new stake was Hasbro: 6,324 shares worth $457K. The largest sale was Avidity Biosciences, an estimated $3.3M.
By sector, the portfolio is most concentrated in Healthcare at 71% of assets, up from 67% a quarter earlier, followed by Consumer Discretionary and Industrials.
- Alethea Capital Management's largest Q3 2024 buy was Hasbro: 6,324 shares worth $457K.
- Alethea Capital Management added most to Kura Oncology in Q3 2024, an estimated $5.83M increase.
- Alethea Capital Management's biggest Q3 2024 reduction was Avidity Biosciences, cutting an estimated $3.3M.
- Alethea Capital Management fully exited Synchrony in Q3 2024, selling an estimated $574K.
- Alethea Capital Management's ten largest holdings make up 95% of its $138M portfolio in Q3 2024.
- Alethea Capital Management opened 19 new positions and closed 20 in Q3 2024.
- Alethea Capital Management's portfolio value rose 5.1% quarter-over-quarter to $138M.
Based on Alethea Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.